| ALDH1 | Aldehyde dehydrogenase 1 |
| AMPK | AMP-activated protein kinase (AMPK) |
| CDK4/6i | CDK4/6 inhibitors |
| ECAR | Extracellular acidification rate |
| ELISA | Enzyme-linked immunosorbent assay |
| EMT | Epithelial–mesenchymal transition |
| ER+ | Estrogen receptor-positive |
| FBS | Fetal bovine serum |
| FCCP | Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone |
| GDF-15 | Growth/differentiation factor 15 |
| H&E | Hematoxylin and eosin |
| HMGB1 | High mobility group box 1 protein |
| IGFBP-2 | Insulin like growth factor binding protein 2 |
| IL-1α | Interleukin-1alpha |
| IL-6 | Interleukin-6 |
| IL-8 | Interleukin-8 |
| MEM | Minimum Essential Medium |
| MiDAS | Mitochondrial dysfunction associated senescence |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B |
| OCR | Oxygen consumption rate |
| OXPHOS | Oxidative phosphorylation |
| PAI-1 | Plasminogen activator inhibitor-1 |
| PDGF-AA | Platelet-derived growth factor AA |
| RANTES | Regulated upon activation, normal T-cell expressed, and secreted |
| SA-β-Gal | Senescence-associated β-galactosidase |
| SASP | Senescence-associated secretory phenotype |
| SDS-PAGE | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis |
| TIS | Therapy-induced senescence |
| TMRE | Tetramethylrhodamine ethyl ester |
| VEGF | Vascular endothelial growth factor |
| 2PR | Palbociclib-resistant LCC2 subline |
| 9PR | Palbociclib-resistant LCC9 subline |
| TPR | Palbociclib-resistant T47D subline |
| 2AR | Abemaciclib-resistant LCC2 subline |
| 9AR | Abemaciclib-resistant LCC9 subline |
| TAR | Abemaciclib-resistant T47D subline |